ascopubs.org

Radium-223 chloride, a first-in-class alpha-pharmaceutical with a benign safety profile for patients with castration-resistant prostate cancer (CRPC) and bone metastases ...

Initial feasibility and safety results from a phase II/III clinical trial to evaluate docetaxel (D) therapy in combination with zoledronic acid (ZA) ± strontium-89 (Sr89) in hormone-refractory ...
ascopubs.org

Radium-223 chloride, a first-in-class alpha-pharmaceutical for patients with castration-resistant prostate cancer (CRPC) and bone metastases: Biodistribution/dosimetry compared ...

Retrospective study to evaluate prostate cancer screening in a resident practice at a major teaching hospital. Background: Radium-223 chloride (Alpharadin) is a first-in-class targeted ...